“…14 Specifically, we show significant induction of a cluster of canonical antiviral genes (including DDX58 [RIG-I], IFIT1, IRF7, ISG15, and OAS3) typical of viral infection in mammals, but strikingly, almost no significant changes in expression of traditional markers of adaptive immunity or inflammation, including the cytokines and chemokines IFNg, CCL8, FAS, and IL6, normally associated with MARV pathogenesis in primates. 8,25,[27][28][29][30][31] Our findings identify putative virulence-determining differences between reservoir and spillover host, as well as immunoprotective commonalities likely shared between ERBs and bat reservoir hosts of other emerging zoonotic pathogens (e.g., SARS, Ebola), which could be exploitable for human therapeutic development.…”